Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      ‘Very concerned’: City watchdog scolds motor finance lenders over £9bn redress scheme

      FCA sign

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Dallas, Boston, New York New Jersey: Inside England’s Fifa World Cup stadiums

      Getty Images logo against a sleek, modern background, representing the influence of media in the business world

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Glengarry Glen Ross at the Old Vic fails to close

      Glengarry Glen Ross production at Old Vic Theatre showcasing intense business negotiations and dramatic performances

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Wednesday 07 January 2015 5:47 am

Silicon Valley was right to invest in DNA: Facebook and Google-backed personal genetics business strikes $10m deal with Genentech

By: Sarah Spickernell

Add as a preferred source on Google

Facebook and Google will be pleased about their decision to invest in personal genetics business 23andMe.
 
The firm, which sells DNA testing kits to individual customers for $99 (£65) each, has secured a major deal with Genentech – a subsidiary of Roche. 
 
According to Forbes, 23andMe is receiving an upfront payment from Genentech of $10m, with further payments of as much as $50m to follow. 
 
The biotech firm was attracted to 23andMe because of the access the deal will provide to a whole wealth of personal DNA data: nearly all of 23andMe's 800,000 customers agreed to have their sequenced genome donated for third party research.  
 
In the case of Genentech, the data will be used to study Parkinson's disease – a hereditary disorder which causes the central nervous system to stop working properly. 12,000 Parkinson's patients and 1,300 of their family members have signed up to 23andMe. 

ATTRACTING DEALS ACROSS THE SECTOR

Genetech is not the only firm to have a keen interest in the DNA database – 23andMe has signed nine other deals with large biotech and pharmaceutical companies. In fact, the company has been collaborating with businesses in the sector since it was founded in 2006. 
 
Last year, it signed a contract with American giant Pfizer to enroll over 10,000 bowel disorder patients. These people will help Pfizer study the genetic causes of diseases such as colitis or Crohn’s disease.
 
“I think that this illustrates how pharma companies are interested in the fact that we have a massive amount of information,” 23andMe's co-founder and chief executive Anne Wojcicki told Forbes.
 
“We have a very engaged consumer population, and these people want to participate in research. And we can do things much faster and more efficiently than any other research means in the world.”
 
From 23andMe's point of view, the revenue brought in by these major deals is much higher than the payments received from customers who buy the personal DNA testing kits. Just one of these deals can bring in twice as much money as all of the business's customer base. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Facebook
  • Google

Trending Articles

  • Who could be Andy Burnham’s Chancellor? 

  • As it happened: FTSE 100 finishes higher as US-Iran talks progress and Starmer resigns; Space X shares fall after bond sale

  • Starmer will resign, Trump says

  • Coca-Cola brings in restructuring lineup over failed Costa sale

  • Ocado to replace founder Steiner as shares plunge 

More from CityAM

  • ‘Very concerned’: City watchdog scolds motor finance lenders over £9bn redress scheme

    Banking
    FCA sign
  • Motor finance revs up City watchdog’s PR spend

    Regulation
    Close Brothers has been swallowed up in the motor finance saga.
  • Dallas, Boston, New York New Jersey: Inside England’s Fifa World Cup stadiums

    Sport Business
    Getty Images logo against a sleek, modern background, representing the influence of media in the business world
  • Manchester United secure site for new stadium after switching location

    Sport Business
    Foster Partners architecture firm showcases innovative building design, highlighting sustainable and modern elements in ur...
  • SpaceX kicks off bond sale as it looks to begin mass borrowing spree

    Markets
    Elon Musk discussing SpaceX investment as Scottish Mortgages largest holding on a business news platform
  • Baillie Gifford launches UK’s first ever tokenised fund

    Investing
    Baillie Giffords Edinburgh headquarters with SpaceX investor branding prominently displayed on the modern office building ...
  • Speed or stability? Bond markets strap in for Andy Burnham coronation

    Economics
    Andy Burnham smiling at a public event, wearing a suit and tie, representing positive leadership and community engagement.
  • Streeting backs Burnham as ‘King of the North’ calls for ‘orderly’ transfer of power

    Politics
    Andy Burnham Westminster

CityAM Canada — business, markets and opinion for Canadian readers.

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Contact

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies